title: Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.
abstract: The relative potency of interferon alpha (IFN alpha), interferon beta (IFN beta), and interferon gamma (IFN gamma) in inducing the expression of HLA class I antigens, as well as their capacity to counteract the inhibition induced by glucocorticoid hormones on HLA class I antigen expression, were analysed in the human melanoma cell line M14, both at membrane and at mRNA level. The data obtained indicate that (a) IFN enhance with different potency (IFN gamma > IFN beta > IFN alpha) the expression of HLA class I antigens in M14 cells, (b) prednisone inhibits HLA class I antigen expression, (c) glucocorticoid hormones, when associated with IFN alpha or IFN gamma, inhibit the HLA class I enhancement induced by IFN alone, and, finally, (c) the association between 1 microM prednisone or 1 microM deflazacort and IFN beta seems to potentiate the enhancing capacity of IFN on the expression of HLA class I molecules at the mRNA level. These findings, if confirmed, might indicate that IFN and glucocorticoid hormones are not mutually exclusive in the management of human melanoma.
authors.affiliation: Department of Internal Medicine (D.I.M.I.), University of Genoa, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Lanza
authors.forename: L
authors.initials: L
authors.lastname: Peirano
authors.forename: O
authors.initials: O
authors.lastname: Bosco
authors.forename: P
authors.initials: P
authors.lastname: Contini
authors.forename: G
authors.initials: G
authors.lastname: Filaci
authors.forename: M
authors.initials: M
authors.lastname: Setti
authors.forename: F
authors.initials: F
authors.lastname: Puppo
authors.forename: F
authors.initials: F
authors.lastname: Indiveri
authors.forename: M
authors.initials: M
authors.lastname: Scudeletti
mesh_terms: D004357:Drug Synergism; D015870:Gene Expression / Q000187:drug effects; D005938:Glucocorticoids / Q000494:pharmacology*; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007372:Interferons / Q000494:pharmacology*; D008545:Melanoma / Q000276:immunology*; D011241:Prednisone / Q000494:pharmacology; D011282:Pregnenediones / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
chemical_list: D005938:Glucocorticoids; D015395:Histocompatibility Antigens Class I; D011282:Pregnenediones; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D007372:Interferons; C021988:deflazacort; D011241:Prednisone